Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
Francisco AlmeidaA MacedoD TrigoM AbreuM GuimarãesN LuísR PinhoR TavaresPublished in: HIV medicine (2020)
Neurocognitive impairment (both scales altered) was present in 35.8%, which is comparable to what is described for HIV-1. The MoCA performed worse in the migrant population and might not be applicable in this setting.